{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:16:08Z","timestamp":1791432968825,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82088101, 81930013, 82070338, 82222008, 82470330, and 82400388"],"award-info":[{"award-number":["82088101, 81930013, 82070338, 82222008, 82470330, and 82400388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59096-4","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T18:34:01Z","timestamp":1745087641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["SNAP25-dependent membrane trafficking of the Kv1.5 channel regulates the onset of atrial fibrillation"],"prefix":"10.1038","volume":"16","author":[{"given":"Xuling","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qicheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2651-2202","authenticated-orcid":false,"given":"Duanyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-1835","authenticated-orcid":false,"given":"Yi-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"59096_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","volume":"8","author":"B Brundel","year":"2022","unstructured":"Brundel, B. et al. Atrial fibrillation. Nat. Rev. Dis. Prim. 8, 21 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"59096_CR2","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1001\/jama.2020.23700","volume":"325","author":"JR Baman","year":"2021","unstructured":"Baman, J. R. & Passman, R. S. Atrial Fibrillation. Jama 325, 2218 (2021).","journal-title":"Jama"},{"key":"59096_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMcp2023658","volume":"384","author":"GF Michaud","year":"2021","unstructured":"Michaud, G. F. & Stevenson, W. G. Atrial Fibrillation. N. Engl. J. Med. 384, 353\u2013361 (2021).","journal-title":"N. Engl. J. Med."},{"key":"59096_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","volume":"23","author":"DJ Seiffge","year":"2024","unstructured":"Seiffge, D. J. et al. Secondary stroke prevention in people with atrial fibrillation: treatments and trials. Lancet Neurol. 23, 404\u2013417 (2024).","journal-title":"Lancet Neurol."},{"key":"59096_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/eurheartj\/ehac696","volume":"44","author":"ES Spatz","year":"2023","unstructured":"Spatz, E. S. & Herrin, J. Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag. Eur. Heart J. 44, 205\u2013207 (2023).","journal-title":"Eur. Heart J."},{"key":"59096_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s40265-023-01923-3","volume":"83","author":"A Saljic","year":"2023","unstructured":"Saljic, A., Heijman, J. & Dobrev, D. Recent Advances in Antiarrhythmic Drug Therapy. Drugs 83, 1147\u20131160 (2023).","journal-title":"Drugs"},{"key":"59096_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1124\/pr.117.014183","volume":"70","author":"D Calvo","year":"2018","unstructured":"Calvo, D., Filgueiras-Rama, D. & Jalife, J. Mechanisms and Drug Development in Atrial Fibrillation. Pharmacol. Rev. 70, 505\u2013525 (2018).","journal-title":"Pharmacol. Rev."},{"key":"59096_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","volume":"388","author":"IC Van Gelder","year":"2016","unstructured":"Van Gelder, I. C., Rienstra, M., Crijns, H. J. & Olshansky, B. Rate control in atrial fibrillation. Lancet (Lond., Engl.) 388, 818\u2013828 (2016).","journal-title":"Lancet (Lond., Engl.)"},{"key":"59096_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCRESAHA.120.316576","volume":"127","author":"YS Ang","year":"2020","unstructured":"Ang, Y. S., Rajamani, S., Haldar, S. M. & H\u00fcser, J. A New Therapeutic Framework for Atrial Fibrillation Drug Development. Circulation Res. 127, 184\u2013201 (2020).","journal-title":"Circulation Res."},{"key":"59096_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/S0140-6736(10)60096-7","volume":"375","author":"D Dobrev","year":"2010","unstructured":"Dobrev, D. & Nattel, S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet (Lond., Engl.) 375, 1212\u20131223 (2010).","journal-title":"Lancet (Lond., Engl.)"},{"key":"59096_CR11","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/cvr\/cvab177","volume":"118","author":"F Wiedmann","year":"2022","unstructured":"Wiedmann, F. et al. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovascular Res. 118, 1728\u20131741 (2022).","journal-title":"Cardiovascular Res."},{"key":"59096_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","volume":"127","author":"S Nattel","year":"2020","unstructured":"Nattel, S., Heijman, J., Zhou, L. & Dobrev, D. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. Circulation Res. 127, 51\u201372 (2020).","journal-title":"Circulation Res."},{"key":"59096_CR13","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","volume":"114","author":"J Heijman","year":"2014","unstructured":"Heijman, J., Voigt, N., Nattel, S. & Dobrev, D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circulation Res. 114, 1483\u20131499 (2014).","journal-title":"Circulation Res."},{"key":"59096_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1152\/physrev.00022.2013","volume":"94","author":"N Schmitt","year":"2014","unstructured":"Schmitt, N., Grunnet, M. & Olesen, S. P. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia. Physiological Rev. 94, 609\u2013653 (2014).","journal-title":"Physiological Rev."},{"key":"59096_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tips.2021.03.005","volume":"42","author":"S Burg","year":"2021","unstructured":"Burg, S. & Attali, B. Targeting of Potassium Channels in Cardiac Arrhythmias. Trends Pharmacol. Sci. 42, 491\u2013506 (2021).","journal-title":"Trends Pharmacol. Sci."},{"key":"59096_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/01.RES.0000096362.60730.AE","volume":"93","author":"D Fedida","year":"2003","unstructured":"Fedida, D. et al. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Circulation Res. 93, 744\u2013751 (2003).","journal-title":"Circulation Res."},{"key":"59096_CR17","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/eurheartj\/ehs442","volume":"34","author":"IE Christophersen","year":"2013","unstructured":"Christophersen, I. E. et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur. Heart J. 34, 1517\u20131525 (2013).","journal-title":"Eur. Heart J."},{"key":"59096_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1161\/CIRCRESAHA.108.192773","volume":"104","author":"SM Schumacher","year":"2009","unstructured":"Schumacher, S. M. et al. Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5. Circulation Res. 104, 1390\u20131398 (2009).","journal-title":"Circulation Res."},{"key":"59096_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/bja\/aer278","volume":"107","author":"P Friederich","year":"2011","unstructured":"Friederich, P. & Pfizenmayer, H. The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient. Br. J. Anaesth. 107, 644\u2013645 (2011).","journal-title":"Br. J. Anaesth."},{"key":"59096_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2016.10.003","volume":"176","author":"U Ravens","year":"2017","unstructured":"Ravens, U. & Odening, K. E. Atrial fibrillation: Therapeutic potential of atrial K(+) channel blockers. Pharmacol. Therapeutics 176, 13\u201321 (2017).","journal-title":"Pharmacol. Therapeutics"},{"key":"59096_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0008-6363(03)00543-1","volume":"60","author":"KJ Wirth","year":"2003","unstructured":"Wirth, K. J. et al. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. Cardiovascular Res. 60, 298\u2013306 (2003).","journal-title":"Cardiovascular Res."},{"key":"59096_CR22","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1073\/pnas.0902809106","volume":"106","author":"E Balse","year":"2009","unstructured":"Balse, E. et al. Cholesterol modulates the recruitment of Kv1.5 channels from Rab11-associated recycling endosome in native atrial myocytes. Proc. Natl Acad. Sci. USA 106, 14681\u201314686 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59096_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.RES.0000179535.06458.f8","volume":"97","author":"WS Choi","year":"2005","unstructured":"Choi, W. S. et al. Kv1.5 surface expression is modulated by retrograde trafficking of newly endocytosed channels by the dynein motor. Circulation Res. 97, 363\u2013371 (2005).","journal-title":"Circulation Res."},{"key":"59096_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/CIRCRESAHA.114.302711","volume":"114","author":"SM Schumacher-Bass","year":"2014","unstructured":"Schumacher-Bass, S. M. et al. Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes. Circulation Res. 114, 982\u2013992 (2014).","journal-title":"Circulation Res."},{"key":"59096_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1210\/er.2007-0010","volume":"28","author":"YM Leung","year":"2007","unstructured":"Leung, Y. M., Kwan, E. P., Ng, B., Kang, Y. & Gaisano, H. Y. SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr. Rev. 28, 653\u2013663 (2007).","journal-title":"Endocr. Rev."},{"key":"59096_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/gast.2002.32412","volume":"122","author":"J Ji","year":"2002","unstructured":"Ji, J. et al. SNAP-25, a SNARE protein, inhibits two types of K channels in esophageal smooth muscle. Gastroenterology 122, 994\u20131006 (2002).","journal-title":"Gastroenterology"},{"key":"59096_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neuron.2009.07.017","volume":"63","author":"S Selak","year":"2009","unstructured":"Selak, S. et al. A role for SNAP25 in internalization of kainate receptors and synaptic plasticity. Neuron 63, 357\u2013371 (2009).","journal-title":"Neuron"},{"key":"59096_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1523\/JNEUROSCI.4933-08.2010","volume":"30","author":"CG Lau","year":"2010","unstructured":"Lau, C. G. et al. SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking. J. Neurosci.: Off. J. Soc. Neurosci. 30, 242\u2013254 (2010).","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"59096_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.007097","volume":"12","author":"L Geng","year":"2019","unstructured":"Geng, L. et al. SNX17 (Sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (Potassium Voltage-Gated Channel Subfamily A Member 5) Channel. Circulation Arrhythmia Electrophysiol. 12, e007097 (2019).","journal-title":"Circulation Arrhythmia Electrophysiol."},{"key":"59096_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/01.CIR.103.5.684","volume":"103","author":"BJ Brundel","year":"2001","unstructured":"Brundel, B. J. et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103, 684\u2013690 (2001).","journal-title":"Circulation"},{"key":"59096_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCRESAHA.123.322508","volume":"133","author":"JL Sanchez-Alonso","year":"2023","unstructured":"Sanchez-Alonso, J. L. et al. Functional LTCC-\u03b2(2)AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure. Circulation Res. 133, 120\u2013137 (2023).","journal-title":"Circulation Res."},{"key":"59096_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1222","volume":"10","author":"GE Brown","year":"2024","unstructured":"Brown, G. E. et al. Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation. Sci. Adv. 10, eadg1222 (2024).","journal-title":"Sci. Adv."},{"key":"59096_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCRESAHA.118.313518","volume":"124","author":"F Guo","year":"2019","unstructured":"Guo, F. et al. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome. Circulation Res. 124, 66\u201378 (2019).","journal-title":"Circulation Res."},{"key":"59096_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.15252\/emmm.201404757","volume":"7","author":"HD Devalla","year":"2015","unstructured":"Devalla, H. D. et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7, 394\u2013410 (2015).","journal-title":"EMBO Mol. Med."},{"key":"59096_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuron.2020.10.012","volume":"109","author":"B Alten","year":"2021","unstructured":"Alten, B. et al. Role of Aberrant Spontaneous Neurotransmission in SNAP25-Associated Encephalopathies. Neuron 109, 59\u201372.e55 (2021).","journal-title":"Neuron"},{"key":"59096_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature23484","volume":"548","author":"Q Zhou","year":"2017","unstructured":"Zhou, Q. et al. The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis. Nature 548, 420\u2013425 (2017).","journal-title":"Nature"},{"key":"59096_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41580-023-00668-x","volume":"25","author":"R Jahn","year":"2024","unstructured":"Jahn, R., Cafiso, D. C. & Tamm, L. K. Mechanisms of SNARE proteins in membrane fusion. Nat. Rev. Mol. Cell Biol. 25, 101\u2013118 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59096_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.111.263525","volume":"111","author":"LK Svoboda","year":"2012","unstructured":"Svoboda, L. K. et al. Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5. Circulation Res. 111, 842\u2013853 (2012).","journal-title":"Circulation Res."},{"key":"59096_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41580-018-0053-7","volume":"19","author":"PJ Cullen","year":"2018","unstructured":"Cullen, P. J. & Steinberg, F. To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nat. Rev. Mol. Cell Biol. 19, 679\u2013696 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59096_CR40","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/cvr\/cvae169","volume":"120","author":"JS Reyat","year":"2024","unstructured":"Reyat, J. S. et al. PITX2 deficiency leads to atrial mitochondrial dysfunction. Cardiovascular Res. 120, 1907\u20131923 (2024).","journal-title":"Cardiovascular Res."},{"key":"59096_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.120.316366","volume":"127","author":"D Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler, D. et al. Animal Models of Atrial Fibrillation. Circulation Res. 127, 91\u2013110 (2020).","journal-title":"Circulation Res."},{"key":"59096_CR42","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/CIRCEP.111.969782","volume":"5","author":"BB Pavri","year":"2012","unstructured":"Pavri, B. B. et al. MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans. Circulation Arrhythmia Electrophysiol. 5, 1193\u20131201 (2012).","journal-title":"Circulation Arrhythmia Electrophysiol."},{"key":"59096_CR43","doi-asserted-by":"publisher","first-page":"H71","DOI":"10.1152\/ajpheart.00260.2008","volume":"296","author":"ME Loewen","year":"2009","unstructured":"Loewen, M. E. et al. Shared requirement for dynein function and intact microtubule cytoskeleton for normal surface expression of cardiac potassium channels. Am. J. Physiol. Heart Circ. Physiol. 296, H71\u2013H83 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"59096_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.10.001","volume":"183","author":"B Goversen","year":"2018","unstructured":"Goversen, B., van der Heyden, M. A. G., van Veen, T. A. B. & de Boer, T. P. The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on I(K1). Pharmacol. Therapeutics 183, 127\u2013136 (2018).","journal-title":"Pharmacol. Therapeutics"},{"key":"59096_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107925","volume":"32","author":"DAM Feyen","year":"2020","unstructured":"Feyen, D. A. M. et al. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Rep. 32, 107925 (2020).","journal-title":"Cell Rep."},{"key":"59096_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijsu.2019.10.015","volume":"72","author":"NB Robinson","year":"2019","unstructured":"Robinson, N. B. et al. The current state of animal models in research: A review. Int. J. Surg. (Lond., Engl.) 72, 9\u201313 (2019).","journal-title":"Int. J. Surg. (Lond., Engl.)"},{"key":"59096_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCRESAHA.118.313811","volume":"124","author":"L Ni","year":"2019","unstructured":"Ni, L. et al. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector. Circulation Res. 124, 256\u2013262 (2019).","journal-title":"Circulation Res."},{"key":"59096_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCRESAHA.118.314394","volume":"124","author":"AH Maass","year":"2019","unstructured":"Maass, A. H. Atrial-Specific Gene Transfer. Circulation Res. 124, 180\u2013182 (2019).","journal-title":"Circulation Res."},{"key":"59096_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.120.045791","volume":"142","author":"HM Campbell","year":"2020","unstructured":"Campbell, H. M. et al. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. Circulation 142, 1159\u20131172 (2020).","journal-title":"Circulation"},{"key":"59096_CR50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41422-021-00499-5","volume":"31","author":"D Xie","year":"2021","unstructured":"Xie, D. et al. Identification of an endogenous glutamatergic transmitter system controlling excitability and conductivity of atrial cardiomyocytes. Cell Res. 31, 951\u2013964 (2021).","journal-title":"Cell Res."},{"key":"59096_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/CIRCRESAHA.119.315641","volume":"126","author":"K Tazmini","year":"2020","unstructured":"Tazmini, K. et al. Hypokalemia Promotes Arrhythmia by Distinct Mechanisms in Atrial and Ventricular Myocytes. Circulation Res. 126, 889\u2013906 (2020).","journal-title":"Circulation Res."},{"key":"59096_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41421-022-00429-8","volume":"8","author":"D Xie","year":"2022","unstructured":"Xie, D. et al. Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation. Cell Discov. 8, 76 (2022).","journal-title":"Cell Discov."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59096-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T20:01:22Z","timestamp":1745092882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59096"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59096-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3730"}}